CAL
AKYA

Capital Advisors Ltd’s Akoya BioSciences AKYA Stock Holding History

Capital Advisors Ltd’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-59
Closed – – 1352
2024
Q1 		$0 Hold
59
– – ﹤0.01% 1327
2023
Q4 		$0 Buy
+59
New +$245 ﹤0.01% 1266
2022
Q4 		– Sell
-36
Closed – – 1183
2022
Q3 		$0 Hold
36
– – ﹤0.01% 1210
2022
Q2 		$0 Buy
+36
New +$373 ﹤0.01% 970

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Capital Advisors Ltd's AKYA Position: Q2 2024 in Review

Capital Advisors Ltd sold out of Akoya BioSciences (AKYA) in Q2 2024, closing a stake of 59 shares.

Capital Advisors Ltd first reported a position in AKYA in Q2 2022 and held it in 4 quarters. The position peaked at $0 in Q1 2024. 59 funds tracked by Wall St. Rank hold AKYA as of Q2 2024.

  • Capital Advisors Ltd reported no remaining Akoya BioSciences position as of Q2 2024 after selling out during the quarter.
  • Capital Advisors Ltd sold 59 Akoya BioSciences shares in Q2 2024.
  • Capital Advisors Ltd first reported a position in Akoya BioSciences in Q2 2022 and held it in 4 quarters.
  • Capital Advisors Ltd's Akoya BioSciences position peaked at $0 in Q1 2024.
  • 59 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2024.

Based on Capital Advisors Ltd's 13F filing for Q2 2024, filed 25 Jul 2024.